Epstein Secrets

f this report. Investors should consider this report as only a single factor in making their investment decision. EFTA00306883 Chris Schott. CFA North America Equity Research (1-212) 622-5676 02 June 2010 J.P.Morgan Investment Thesis, Valuation and Risks Merck & Co., Inc. (Overweight: Price Target: $64.00) Investment

ng the executed price by the commission rate which was individually agreed between JPMorgan Securities Japan Co.. Ltd., and the customer in advance. Financial Instruments Firms: JPMorgan Securities Japan Co.. Ltd., Kanto Local Finance Bureau (kinsho) No. 82 Participating Association! Japan Securities Dealers Association. Th

alcolm Barr, Senior European Economist; • Pavan Wadhwa, Global Head of Interest Rate Strategy, Nikolaos Panigirtzoglou, Global Market Strategist. North America Equity Research 26 June 2012 Portfolio Strategy Thomas J Lee, CPAAc J.P. Morgan Securities LLC hor J.P. Morgan Secunties LLC Economic and Policy Research Malc

ng the executed price by the commission rate which was individually agreed between JPMorgan Securities Japan Co., Ltd., and the customer in advance. Financial Instruments Firms: JPMorgan Securities Japan Co.. Ltd., Kanto Local Finance Bureau 4 EFTA00606083 North America Equity Research 26 June 2012 J.P.Morgan (kinsho)

1.23 1.44 1.48 FY 3.15 3.95 4.00 5.10 5.20 Bloomberg EPS FY (s) 3.10 3.98 5.10 Source: Company data. Bloomberg. J.P. Morgan estimates. North America Equity Research 12 June 2014 Overweight HAL, HAL US Price: $66.94 A Price Target: $78.00 Previous: $77.00 Oil Services and Equipment J. David Anderson, PE, C

on. PE. CFA North America Equity Research 12 June 2014 J.PMorgan agreed between JPMorgan Securities Japan Co.. Ltd., and the customer in advance. Financial Instruments Firms: JPMorgan Securities Japan Co.. Ltd., Kanto Local Finance Bureau (kinsho) No. 82 Participating Association / Japan Securities Dealers Association. T

n I/O compounds (GITR), BACE-inhibitor (Alzheimer's) and anaceptrapib (CETP), none of which appear to be reflected in Merck's current share price. North America Equity Research 02 October 2015 Pharmaceuticals — Major & Specialty Chris Schott, CFA AC (1-212)622-5676 Bloomberg JPMA SCHOTT <GO, Aditl Singhania, PhD (1-212

ng the executed price by the commission rate which was individually agreed between JPMorgan Securities Japan Co.. Ltd.. and the customer in advance. Financial Instruments Firms: JPMorgan Securities Japan Co.. Ltd.. Kanto Local Finance Bureau (kinsho) No. 82 Participating Association / Japan Securities Dealers Association, T

J.P. Morgan North America Equity Research 24 April 2014 Boeing Company Q1 Encouraging on Several Fronts; Raising Estimates and Price Target Q1 contained several positive developments: 1)

ng the executed price by the commission rate which was individually agreed between JPMorgan Securities Japan Co.. Ltd.. and the customer in advance. Financial Instruments Firms: JPMorgan Securities Japan Co.. Ltd.. Kanto Local Finance Bureau (kinsho) No. 82 Participating Association /Japan Securities Dealers Association. Th

hat could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. North America Equity Research 08 May 2014 Overweight CAR, CAR US Price: $51.79 A Price Target: $59.00 Previous: $53.00 Leisure Kevin Milota AC Bloomberg JPMA MILOTA <GO>

ng the executed price by the commission rate which was individually agreed between JPMorgan Securities Japan Co.. Ltd.. and the customer in advance. Financial Instruments Firms: JPMorgan Securities Japan Co.. Ltd., Kanto Local Finance Bureau (kinsho) No. 82 Participating Association / Japan Securities Dealers Association. T